• Fe3O4@ZIF-8 for Jaw Osteomyelitis

  2026-09-04

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function strategy for jaw osteomyelitis, combining pH-responsive Zn2+ release for antibacterial activity with magnetically supported bone regeneration. Its main innovation is the coordination of bacterial membrane disruption, heat-shock suppression, and osteogenic effects within one nanomaterial platform.

• PreScission Protease: From Tag Cleavage to Assay Design

  2026-09-04

  PreScission Protease enables sequence-specific HRV 3C protease cleavage at low temperature. This guide connects fusion-tag engineering with assay design, using a Drosophila nuclear-architecture study to show how purified proteins can support stronger mechanistic conclusions.

• CCG-1423: Reading RhoA Signaling in Context

  2026-09-03

  CCG-1423 is a RhoA inhibitor that helps separate transcriptional signaling from ROCK-dependent cytoskeletal effects. This article interprets its mechanism alongside new evidence on RhoA/ROCK signaling, tight-junction remodeling, cancer research, and apoptosis assay design.

• Leucomycin: From Chemical Quality to Assay Insight

  2026-09-03

  Leucomycin (kitasamycin) is more than a macrolide antibiotic: its multicomponent composition directly shapes assay interpretation. This guide connects analytical quality control with translational inhibition studies, bacterial growth inhibition assays, and macrolide resistance characterization.

• NBC19: NLRP3 Inflammasome Workflow Guide

  2026-09-02

  NBC19 supports nanomolar interrogation of NLRP3 signaling in differentiated THP-1 cells, with distinct use cases for Nigericin- and ATP-induced inflammasome activation. This guide combines assay design, compound-handling controls, lactate–HMGB1 biology, and troubleshooting strategies for reproducible inflammation research.

• BHA as a Translational Redox Control

  2026-09-02

  Butylated hydroxyanisole (BHA) is more than a generic antioxidant control: used deliberately, it can help translational researchers distinguish reactive oxygen species effects from assay artifacts, cytotoxicity, and downstream pathway changes. This thought-leadership article connects BHA workflow design with lessons from peptide drug development, emphasizing reproducibility, mechanistic restraint, and decision-ready evidence.

• Perospirone: SM-9018 Free Base Assay Guide

  2026-09-01

  Build more informative antipsychotic mechanism studies with Perospirone by pairing 5-HT2A, D2, and 5-HT1A pharmacology with a practical Kv1.5 off-target workflow. This guide connects neuropsychiatric disorder models to vascular electrophysiology while emphasizing solvent control, concentration selection, and assay troubleshooting.

• EGF Signaling as a Translational Assay Lever

  2026-09-01

  Recombinant human EGF is more than a routine cell-culture supplement. This thought-leadership article explains how defined EGF receptor binding can improve assay reproducibility, sharpen interpretation of cell proliferation and differentiation, and support translational studies that distinguish growth-factor context from cancer-cell dependency. It also connects disciplined EGF assay design with recent chemogenetic evidence identifying EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer.

• CLCC1 Drives Herpesvirus Nuclear Egress Fusion

  2026-08-31

  A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of herpesvirus nuclear egress. Genetic screening, cell biology, and evolutionary analysis connect CLCC1 loss with perinuclear capsid accumulation, impaired nuclear pore insertion, and reduced viral production, while also suggesting a broader role in nuclear-envelope morphogenesis.

• Mianserin HCl in Applied Receptor Research

  2026-08-31

  Mianserin HCl provides a practical pharmacological probe for 5-HT2 signaling, noradrenergic modulation, and psychiatric disorder research. Its emerging use in β-cyclodextrin complexation and antipathogenic assays makes it more than a conventional antidepressant research compound, but each application requires careful controls.

• Dacomitinib and the Ferroptosis Research Frontier

  2026-08-30

  Dacomitinib (PF-00299804) offers translational researchers a powerful way to interrogate irreversible pan-HER signaling blockade, resistance biology, and cancer cell fate. This article connects its established EGFR, HER2, and HER4 activity with the mitochondrial ferroptosis findings reported for METTL17 in colorectal cancer, while clearly separating evidence from forward-looking hypotheses.

• Streptavidin-Cy3 for NPC Metastasis Assays

  2026-08-29

  Use Streptavidin-Cy3 to convert biotinylated antibodies, nucleic-acid probes, and proteins into a bright Cy3 signal across NPC imaging and flow workflows. This guide connects super-enhancer RNA biology with practical assay design, controls, optimization, and interpretation limits.

• Propranolol and Essential Tremor: TMS Evidence

  2026-08-28

  A 2024 prospective observational study used paired transcranial magnetic stimulation and cerebellar eyeblink conditioning to distinguish how propranolol and primidone modulate essential tremor. The results associate propranolol response with reduced corticospinal excitability and increased short afferent inhibition, supporting a central noradrenergic–GABAergic contribution alongside its established peripheral actions.

• Safe DNA Gel Stain for RNA-Targeting Workflows

  2026-08-28

  Safe DNA Gel Stain supports sensitive DNA and RNA gel imaging while enabling blue-light workflows that can protect cloning materials from unnecessary UV exposure. This article explains how gel-based quality control complements, but does not replace, structure-guided RNA methods such as cgSHAPE-seq.

• Tricine-SDS-PAGE Gel Preparation Kit: Practical Guide

  2026-08-27

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving small proteins and peptides that may be poorly separated by conventional Tris-glycine systems, especially across the 1–10 kDa range. It is a research-use gel preparation product for denaturing or non-denaturing workflows and should not be used for diagnostic, clinical, or medical applications.

7964 records 1/531 page Next 12345 下5页 Last page